Monday, March 17, 2014

Pharmacological interventions for preventing complications in idiopathic hypercalciuria: 2009 Cochr


Pharmacological interventions for preventing complications in idiopathic hypercalciuria: 2009 Cochrane Review Group Hospital in Reus (J.Escribano) vih Abstract Pharmacological interventions for preventing complications in idiopathic hypercalciuria idiopathic ipercalciuria H is a hereditary metabolic disorder vih characterized by the excessive amount vih of calcium excreted in the urine in patients with normal serum calcium levels. The main complications of this disease in adults are the formation of kidney stones and bone loss. In children, it can cause recurrent hematuria (blood in the urine), dysuria, vih urinary tract infection, abdominal pain and back pain. The aim of this review was to assess the benefits and harms of pharmacological treatments for the prevention vih of complications of idiopathic hypercalciuria. We identified four studies that compared the thiazide (diuretic) or standard treatment for clinical monitoring and increased water intake or specific dietary recommendations and a comparative study of thiazide and potassium salt. There was a decrease in the number of new stones in the group that received thiazide, vih as well as an increase in the time required vih for the formation of new stones. The addition of potassium salts to thiazide vih significantly reduced the amount of calcium excreted in the urine. No studies in children were identified and there are no studies investigating the use of drug therapy for people with hypercalciuria, but without symptoms.
RSS Pagerank Translation / Translation to Spanish Translate to English Traducir Traduire en français Access Post: You can post annotations by emailing pepestrada. **** **** @ Blogger.com Being our hospital stands Subscription Enter your email and receive free updates Courses Click the button if you want our calendar of courses and sessions Guards Summary Atlas Interactive metasearch Spanish Uro-Internet Protocols SYNFLORIX EMEA approves AEP Nephrology Nephrology evidence-based childhood obesity vih (presentation) Faro Child Health vih Handbook: Observatory Child Health II Refresher Course in PEDIATRIC DERMATOLOGY ...


No comments:

Post a Comment